Arterial thrombosis and drospirenone-containing pill (Yasmin). Is the pill to be absolutely avoided by women who smoke?

Journal of Thrombosis and Thrombolysis

Volumn 26, Issue 2, 2008, Pages 163-164

  Girolami, Antonio ^a   Tezza, Fabiana ^a   Allemand, Emanuele ^a   Girolami, Bruno ^b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Universit degli Studi di Padova   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; DROSPIRENONE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN; SPIRONOLACTONE;

ARTERY THROMBOSIS; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; CLINICAL TRIAL; DRUG SAFETY; DRUG TOLERABILITY; HEART INFARCTION; HUMAN; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; VEIN THROMBOSIS;

ADOLESCENT; ADULT; ANDROSTENES; ARTERIAL OCCLUSIVE DISEASES; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; RISK ASSESSMENT; RISK FACTORS; SMOKING; THROMBOSIS; YOUNG ADULT;

EID: 56049125288     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0180-z     Document Type: Note

References (20)

1. World Health Organization (1996) Ischemic stroke and combined oral contraceptives: Result of an international multicentre case-control study. Lancet 348:498-505
2. Kemmeren JM (2002) Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study: Oral contraceptives and the risk of ischemic stroke. Stroke 33:1202-1208
3. Rosenberg L (2001) Low-dose oral contraceptive use and the risk of myocardial infarction. Arch Intern Med 161:1065-1070
4. Tanis BC (2001) Oral contraceptives and the risk of myocardial infarction. N Engl J Med 345:1787-1793
5. Chasan-Taber L, Stampfer M (2001) Oral contraceptives and myocardial infarction-the search for the smoking gun. N Engl J Med 345:1841-1842
6. Oelkers W (2000) Drospirenone-a new progestogen with antimineralocorticoid activity, resembling natural progesterone. Eur J Contracept Reprod Health Care 5(Suppl 3):17-24
7. Thorneycroft IH (2002) Yasmin: The reason why. Eur J Contracept Reprod Health Care 7(Suppl 3):13-18
8. Heinemann LA (2004) Safety of a new oral contraceptive containing drospirenone. Drug Saf 27:1001-1018
9. Pearce HM (2005) Deep vein thrombosis and pulmonary embolism reported in the prescription event monitoring study of Yasmin. Br J Clin Pharmacol 60:98-102
10. Van Grootheest K (2003) Thromboembolism associated with the new contraceptive Yasmin. BMJ 326(7383):257
11. Sheldon P (2002) Dutch GPs warned against new contraceptive pill. BMJ 324(7342):869
12. Vandenbroucke JP (2001) Oral contraceptives and the risk of venous thrombosis. N Engl J Med 344:1527-1535
13. Van Vliet HA (2004) Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate. J Thromb Haemost 2:2060-2062
14. Girolami A, Simioni P, Zanardi S, Girolami B (1991) The role of drugs, particularly oral contraceptives in triggering thrombosis in congenital defects of coagulation inhibitors: A study of six patients. Blood Coag Fibrinolysis 2:673-678
15. Girolami A, Tormene D, Gavasso S, Bertolo C, Girolami B (2004) Long-term use of oral contraceptives without thrombosis in patients with FV Leiden polymorphism: A study of 37 patients (2 homozygous and 35 heterozygous). J Thromb Thrombol 17:145-149
16. Vayà A, Mira Y, Ferrando F, Aznar J, Fuster J (2003) Transient ischaemic attack associated with the new contraceptive Yasmin. Thromb Res 112:121-123
17. Cabou C, Lacroix I, Roncalli J, Elbaz M, Caillaux D, Damase-Michel C, Fauvel J, Montastruc J (2006) Infarctus du myocarde chez une jeune femme fumeuse sous contraception orale. Arch Moe Coeur Vaiss 99:80-85
18. Girolami A, Vettore S, Tezza F, Girolami B (2007) Retinal central artery occlusion in a young woman after ten days of a drospirenone-containing oral contraceptive (Yasmin). Thromb Haemost 98:473-474
19. Ortì G, Mira Y, Vayà A (2007) Acute myocardial infarction associated with Yasmin oral contraceptive. Clin Appl Thromb Hemost 13:336-337
20. Dinger JC, Heinemann LA, Kuhl-Habich D (2007) The safety of a drospirenone-containing oral contraceptive: Final results from the European Active Surveillance Study on oral contraceptives based on 142.475 women-years of observation. Contraception 75:344-354